Eli Lilly Sues Teva Again Over Gemzar ANDA
Eli Lilly & Co. has filed another infringement complaint against Teva Pharmaceuticals USA Inc. over efforts to make a generic version of Lilly's cancer treatment Gemzar....To view the full article, register now.
Already a subscriber? Click here to view full article